Trials / Terminated
TerminatedNCT02479438
Gastroesophageal Reflux Disease Prospective Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 744 (actual)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.
Detailed description
All patients in this registry will have a diagnosis of gastroesophageal reflux disease or a similar disease of the stomach, esophagus or digestive tract. Each patient undergoing anti-reflux surgery will be asked to participate in the registry to gather preoperative, intraoperative and postoperative outcomes. The data collected from the registry will be used to assess the outcome of various treatments, both standard and new: some specific areas of interest include the long-term effects of treatment (or no treatment), the progression of the disease over time, and the overall length of survival of the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Diagnosed with GERD | Recording of patient outcomes |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2015-06-24
- Last updated
- 2025-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02479438. Inclusion in this directory is not an endorsement.